YOLFTbeta
PT Charlie Hospital Semarang Tbk

PT Charlie Hospital Semarang Tbk

RSCH · JK · Healthcare / Medical Care Facilities

258.00IDR-2.00 (-0.77%)

Price History

Full chart

Market Stats

Previous Close260.00
Open260.00
Day Range252.00 – 260.00
52-Week Range248.00 – 580.00
Volume1.47M
Market Cap1.48T
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta-0.07
50-Day Avg382.64
200-Day Avg348.84

About

PT Charlie Hospital Semarang Tbk operates private hospitals in Indonesia. It operates through Healthcare Services, Construction Services, and Construction Materials Trading segments. The company's hospitals offer outpatients and inpatient services, including a 24-hour emergency room, specialist polyclinic services, central surgical installation services, intensive care units, Perina, laboratory services, radiology services, pharmacy services, medical checkup and support services, wellness centers, and other supporting facilities. It also engages in the construction, maintenance, and reconstruction of residential, office, industrial, commercial, healthcare, educational, lodging, entertainment/sports, and other buildings; and trading of construction materials. The company was founded in 2019 and is headquartered in Kendal, Indonesia. PT Charlie Hospital Semarang Tbk operates as a subsidiary of PT Wahyu Agung.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOMr. H. Junianto
  • Employees214
  • HeadquartersJaIan Raya Ngabean, Kendal, Indonesia, 51381, Indonesia
  • Websitehttps://charliehospital.co.id

Leadership

  • Mr. H. JuniantoPresident Director · b. 1972
  • Ms. Sri MulyaningsihDirector of Finance & Director · b. 1973
  • Catur Asih PuspitasariHead of the Internal Audit Unit
  • Nur AzizahCorporate Secretary

Financials

Income Statement

Currency: IDR2022-12-312023-12-312024-12-312025-12-31
Total Revenue33.03B42.16B48.50B114.40B
Growth (%)-+27.63%+15.04%+135.86%
Cost of Revenue29.33B30.21B34.62B95.35B
Gross Profit3.70B11.95B13.89B19.05B
Gross Margin11.21%28.34%28.63%16.65%
Operating Expense12.50B13.36B17.03B30.30B
Operating Income-8.80B-1.42B-3.14B-11.25B
Operating Margin-26.63%-3.36%-6.48%-9.83%
Net Income-7.35B-1.11B-3.51B-16.42B
Net Income Margin-22.26%-2.64%-7.24%-14.35%

Balance Sheet

Currency: IDR2022-12-312023-12-312024-12-312025-12-31
Total Assets90.99B154.43B192.47B202.55B
Total Liabilities53.43B3.97B45.51B72.03B
Total Equity37.56B150.46B146.96B130.52B
Cash8.68B1.80B1.81B4.00B

Cash Flow

Currency: IDR2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.46B2.96B4.31B-6.19B
Investing Cash Flow-14.64B-74.53B-44.44B-15.57B
Financing Cash Flow14.58B64.69B40.13B23.96B
Capital Expenditure14.64B74.53B44.53B43.57B

Key Statistics & Ratios

Market Cap1.48T
Enterprise Value1.21T
Trailing P/E0.00
Forward P/E0.00
Price / Sales12.42
Price / Book0.00
Book Value45.47
Revenue (TTM)119.46B
Gross Profit (TTM)23.02B
EBITDA-356.39M
Profit Margin-12.98%
Operating Margin-15.40%
Return on Equity-12.07%
Return on Assets-2.29%
Shares Outstanding2.65B
Shares Float530.00M
Beta-0.07
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%